Financiën Medical Developments International Limited
Aandelen
MVP
AU000000MVP2
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,4150 AUD | -2,35% | -1,19% | -45,39% |
Voorlopige winst- en verliesrekening: Medical Developments International Limited
Fiscaal tijdperk: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Omzet 1 | 23,64 | 25,27 | 22,37 | 32,34 | 33,2 | 41,1 | 48 | 54,6 |
Variatie | - | 6,9% | -11,49% | 44,56% | 2,67% | 23,8% | 16,79% | 13,75% |
EBITDA 1 | 2,695 | -2,223 | -11,72 | -15,13 | -8,2 | -1,4 | 3,4 | 7,7 |
Variatie | - | - | 427,4% | 29,08% | -45,81% | 82,93% | - | 126,47% |
Bedrijfsresultaat (EBIT) 1 | 0,098 | -5,972 | -14,67 | -18,25 | -11,6 | -5,1 | -0,3 | 4 |
Variatie | - | - | 145,63% | 24,38% | -36,42% | 56,03% | 94,12% | - |
Betaalde rente | - | - | - | - | - | - | - | - |
Resultaat voor belastingen (EBT) 1 | 0,321 | -14,98 | - | - | -32,93 | -4,8 | 0,2 | 4,7 |
Variatie | - | - | -100% | - | - | 85,42% | - | 2.250% |
Nettowinst (verlies) 1 | 0,379 | -12,56 | -12,41 | -5,609 | -40,99 | -3,7 | 0,2 | 3,6 |
Variatie | - | - | -1,26% | -54,79% | 630,83% | 90,97% | - | 1.700% |
Datum van publicatie | 20/08/20 | 24/08/21 | 25/08/22 | 31/08/23 | 1/08/24 | - | - | - |
Balansprognose: Medical Developments International Limited
Fiscaal tijdperk: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Nettoschuld 1 | -12,2 | -33,2 | -20,1 | - | -9,74 | -20,4 | -24,9 | -29 |
Variatie | - | -372,13% | -160,54% | - | - | -309,55% | -222,06% | -216,47% |
Datum van publicatie | 20/08/20 | 24/08/21 | 25/08/22 | 31/08/23 | 1/08/24 | - | - | - |
Verwachte kasstroom: Medical Developments International Limited
Fiscaal tijdperk: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 1,492 | 1,247 | 1,199 | 1,784 | 0,793 | 2,1 | 2,2 | 2,2 |
Variatie | - | -16,42% | -3,85% | 48,79% | -55,55% | 164,82% | 4,76% | 0% |
Vrije kasstroom (FCF) 1 | -1,32 | -10,14 | -11,98 | - | -11,57 | 0,7 | 4,5 | 4,1 |
Variatie | - | 667,95% | 18,14% | - | - | -106,05% | 542,86% | -8,89% |
Datum van publicatie | 20/08/20 | 24/08/21 | 25/08/22 | 31/08/23 | 1/08/24 | - | - | - |
Verwachte financiële ratio's: Medical Developments International Limited
Fiscaal tijdperk: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
EBITDA-marge (%) | 11,4% | -8,8% | -52,41% | -46,8% | -24,7% | -3,41% | 7,08% | 14,1% |
EBIT-marge (%) | 0,41% | -23,63% | -65,58% | -56,42% | -34,94% | -12,41% | -0,62% | 7,33% |
EBT-marge (%) | 1,36% | -59,27% | - | - | -99,17% | -11,68% | 0,42% | 8,61% |
Nettomarge (%) | 1,6% | -49,72% | -55,47% | -17,35% | -123,47% | -9% | 0,42% | 6,59% |
FCF-marge (%) | -5,58% | -40,11% | -53,54% | - | -34,86% | 1,7% | 9,38% | 7,51% |
Vrije kasstroom/nettoresultaat (%) | -348,28% | 80,68% | 96,53% | - | 28,23% | -18,92% | 2.250% | 113,89% |
Winstgevendheid | ||||||||
ROA | 0,45% | -5,1% | -12,9% | -5,8% | -51,09% | - | - | - |
ROE | 0,86% | -8,44% | -19,76% | -8,09% | -64,53% | -8% | - | 7% |
Financiële gezondheid | ||||||||
Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
Schuld/vrije kasstroom | - | - | - | - | - | - | - | - |
Kapitaalintensiteit | ||||||||
Kapitaaluitgaven/omzet (%) | 6,31% | 4,93% | 5,36% | 5,52% | 2,39% | 5,11% | 4,58% | 4,03% |
CAPEX / EBITDA (%) | 55,36% | -56,1% | -10,23% | -11,79% | -9,67% | -150% | 64,71% | 28,57% |
CAPEX / FCF (%) | -113,03% | -12,3% | -10,01% | - | -6,85% | 300% | 48,89% | 53,66% |
Bestanddelen per aandeel | ||||||||
Kasstroom per aandeel 1 | 0,00261 | -0,1298 | -0,1512 | - | - | - | - | - |
Variatie | - | -5.075,1% | 16,44% | - | - | - | - | - |
Dividend per aandeel 1 | 0,02 | - | - | - | - | - | - | - |
Variatie | - | - | - | - | - | - | - | - |
Nettoactief per aandeel 1 | - | - | - | - | - | - | - | - |
Variatie | - | - | - | - | - | - | - | - |
WPA 1 | 0,0058 | -0,1835 | - | -0,0666 | -0,475 | -0,033 | 0,002 | 0,032 |
Variatie | - | -3.263,79% | - | - | 613,21% | -93,05% | -106,06% | 1.500% |
Aantal aandelen (in duizend) | 65.623 | 71.265 | 71.305 | 86.305 | 86.305 | 112.658 | 112.658 | 112.658 |
Datum van publicatie | 20/08/20 | 24/08/21 | 25/08/22 | 31/08/23 | 1/08/24 | - | - | - |
2025 * | 2026 * | |
---|---|---|
K/w-verhouding | -12,6x | 208x |
PBR-ratio | - | - |
EV/omzet | 0,64x | 0,46x |
Dividendrendement | - | - |